New 52 Week Low Today

Celsion Corp CLSN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 01/21/22 EST
0.42quote price arrow up+0.03 (+6.82%)
Volume
977
Close
0.3903quote price arrow down-0.0437 (-10.0691%)
Volume
836,854
52 week range
0.39 - 3.48
Loading...
  • Open0.4181
  • Day High0.44
  • Day Low0.3854
  • Prev Close0.434
  • 52 Week High3.48
  • 52 Week High Date02/11/21
  • 52 Week Low0.39
  • 52 Week Low Date01/21/22

Key Stats

  • Market Cap33.78M
  • Shares Out86.56M
  • 10 Day Average Volume0.75M
  • Dividend-
  • Dividend Yield-
  • Beta1.94
  • YTD % Change-27.72

KEY STATS

  • Open0.4181
  • Day High0.44
  • Day Low0.3854
  • Prev Close0.434
  • 52 Week High3.48
  • 52 Week High Date02/11/21
  • 52 Week Low0.39
  • 52 Week Low Date01/21/22
  • Market Cap33.78M
  • Shares Out86.56M
  • 10 Day Average Volume0.75M
  • Dividend-
  • Dividend Yield-
  • Beta1.94
  • YTD % Change-27.72

RATIOS/PROFITABILITY

  • EPS (TTM)-0.29
  • P/E (TTM)-1.34
  • Fwd P/E (NTM)-6.50
  • EBITDA (TTM)-19.598M
  • ROE (TTM)-50.15%
  • Revenue (TTM)500,000.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-3,912.02%
  • Debt To Equity (MRQ)9.79%

EVENTS

  • Earnings Date03/17/2022
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Celsion Corp

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Celsion Corporation (Celsion) is a clinical stage biotechnology company. The Company’s product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer and ThermoDox, a heat-activated liposomal encapsulation of doxorubicin for several cancer indications. Its GEN-1, an IL-12 DNA plasmid vector formed into nanoparticles with a lipopolymeric delivery system, is the product candidate designed via the TheraPlas platform technology. Its...
Jeffrey Church CPA
Chief Financial Officer, Executive Vice President, Company Secretary
Khursheed Anwer Ph.D.
Executive Vice President, Chief Scientific Officer
Nicholas Borys M.D.
Executive Vice President and Chief Medical Officer
Address
997 Lenox Dr Ste 100
Lawrence Township, NJ
08648-2317
United States

Top Peers

SYMBOLLASTCHG%CHG
FWP
Forward Pharma A/S
5.66+0.08+1.43%
GLMD
Galmed Pharmaceuticals Ltd
1.54-0.07-4.45%
WINT
Windtree Therapeutics Inc
1.31-0.11-7.75%
ONCS
OncoSec Medical Inc
0.8167+0.0066+0.81%
RZLT
Rezolute Inc
4.42-0.19-4.12%